Learn More
MP Biomedicals™ Recombinant SARS-CoV-2 S1+S2 ECD Protein (His tag, pre-fusion state)
Shop All MP Biomedicals, Inc ProductsDescription
Recombinant SARS-CoV-2 S1+S2 ECD (S-ECD) Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Val11-Gln1208) of SARS-CoV-2 S1+S2 ECD (S-ECD) (Accession #YP_009724390.1) fused with a 6×His tag at the C-terminus. It is the wildtype sequence in pre-fusion state without any mutation.
- Eukaryotic (Expi293) system-expressed protein
- High bioactivity determined with ELISA
- High purity determined with SDS-PAGE
Specifications
Specifications
| Concentration | 1 mg/mL if dissolve in 100 μL of ddH20 or biological buffer |
| For Use With (Application) | Binding Assay, ELISA, Immune Blocking, Immunoprecipitation, SDS-PAGE, Surface Plasmon Resonance (SPR), Western Blot |
| Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.3 to 7.4 |
| Gene ID (Entrez) | 43740568 |
| Preparation Method | Affinity Chromatography |
| Quantity | 100 μg |
| Regulatory Status | RUO |
| Endotoxin Concentration | < 0.1 EU/μg of the protein by LAL method |
| Gene Alias | S glycoprotein; S protein; Spike glycoprotein |
| Conjugate | Unconjugated |
| Show More |
For research or further manufacturing use only, not for direct human use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.